Document is current
Any future updates will be listed below
-
Authors
Conley, Claire C.
Anderson, Alaina
Rodriguez, Jennifer D.
Kang, Hannah
Taylor, Emily P.
Luck, Conor
Rosas Torres, Jacqueline
Cheraghi, Nora
Newton, Noelle
Niell, Bethany L.
O’Neill, Suzanne C.
Vadaparampil, Susan T.
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation (ASPO-19-002)
National Cancer Institute (K08 CA270402)
- License Information
-
More Information
Article History
Received: 28 May 2024
Accepted: 13 August 2024
First Online: 27 August 2024
Declarations
:
: Dr. Conley has received research funding from Pfizer and NIH/NCI. Dr. Niell has received research funding from NIH/NCI, has a research equipment loan agreement with Hologic Inc., and has received reimbursement for business-related travel from the National Comprehensive Cancer Network. Dr. O’Neill has received research funding from Pfizer, Gilead Sciences, and NIH/NCI. Dr. Vadaparampil has received research funding from NIH/NCI. No other authors have competing interests to disclose.
: All study procedures were reviewed and approved by the Institutional Review Boards at Moffitt Cancer Center (Advarra IRB #00000971) and Georgetown University (IRB #00002479).
:
: The authors affirm that human research participants provided informed consent for the use of their quotes in research publications.
